FDA Brief

Company record

Infusion Options, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Infusion Options, Inc..

Warning letters

  1. Infusion Options, Inc.

    FDA found Infusion Options produced sterile compounded drugs under insanitary conditions and failed 503B labeling and reporting rules.

    High risk